- No strong opportunity cluster is confirmed yet; monitor trend and activity pressure.
2186
HKG
Week ended 07 Aug 2026
Weekly Investor Report
Luye Pharma Group Ltd. · Healthcare · Drug Manufacturers - Specialty & Generic
Latest close
2.13 HKD
4.9%
latest week
Weekly setup
Mixed setup
The weekly trend is not active. Price is -11.4% below the Trend Line and sits at 16.2% of its 52-week range. The latest completed week returned 4.9%, after a 10.9% four-week move. The latest news-sentiment score is 50/100. Near-term considerations: volume confirmation is below normal.
Setup score
27
out of 100
Latest Close
2.13 HKD
7 Aug 2026
1W Return
4.9%
latest completed week
4W Return
10.9%
short-term follow-through
12W Return
-9.4%
quarterly tape
Trend Breadth
23.1%
12 of 52 weeks active
Volume Ratio
0.8x
vs 13-week average
- The trend backdrop is inactive, so price action has not confirmed a constructive regime.
- Price is below the Trend Line, which keeps downside pressure in focus.
- Price is below Fair Value, so the market is still discounting the latest tape.
- Activity pressure is negative, which weakens the current setup.
- Trend Line remains the key weekly regime level.
- Activity pressure is the gauge to monitor for confirmation or fade.
- A volume ratio above 1.5x would show stronger participation in the next move.
Price follow-through
4.9%
Latest completed week; four-week move 10.9%.
Indicator stack
13/50
Trend and activity pressure are weighted against the latest 12-week confirmation window.
Trend backdrop
Active
The trend backdrop defines the current weekly regime.
Patient Capital
Quiet
Activity-pressure buy-signal status for institutional accumulation timing.
Next-Week Expectancy
Negative 43.36%
Historical one-week expectancy contributes to the evidence score when direction is confirmed.
News sentiment
50/100
1 relevant articles in the latest sentiment read.
01 · Price action
Study the full chart
Where price is—and whether the trend supports it
The weekly trend is not active. Price is -11.4% below the Trend Line and sits at 16.2% of its 52-week range. The latest completed week returned 4.9%, after a 10.9% four-week move.
52-week price path
Price vs Trend Line and Fair Value
Price
Trend Line
Fair Value
02 · Volume and demand
Is real participation confirming the move?
Latest weekly volume is 0.8x the 13-week average. Participation is below its recent norm, so price strength is not receiving full volume confirmation.
26-week volume confirmation
Bar height shows volume; colour shows the weekly price direction
13 Feb
20 Feb
27 Feb
6 Mar
13 Mar
20 Mar
27 Mar
3 Apr
10 Apr
17 Apr
24 Apr
1 May
8 May
15 May
22 May
29 May
5 Jun
12 Jun
19 Jun
26 Jun
3 Jul
10 Jul
17 Jul
24 Jul
31 Jul
7 Aug
Up week
Down week
Demand beneath price
Activity pressure and institutional-style signals
These indicators assess whether participation is improving beneath the headline price move. They are supporting evidence, not proof of institutional buying.
Activity pressure path
Latest 0.0712-week average 0.10
12-week confirmation
Trend active0/12Active trend-backdrop weeks in the latest 12-week window.
Positive pressure0/12Weeks with constructive activity pressure in the latest 12-week window.
Positive leadership0/12Weeks with positive relative leadership in the latest 12-week window.
Activity pressure0.07Current proprietary activity-pressure read.
Buy signals0Accumulation signal count in the latest 12 weeks.
Reversal markers0No reversal markers
No recent accumulation markers. No reversal markers.
03 · Momentum and leadership
Is performance persistent—and is the stock leading?
Performance is 10.9% over four weeks, -9.4% over 12 weeks, and -45.1% over one year. The current trend has remained active for 0 consecutive weeks.
Performance by holding period
Active trend streak0 weeks
Active weeks in one year12
Trend breadth23.1%
Activity pressure vs relative leadership
Activity pressureRelative leadership
Pressure-0.28Latest activity-pressure read.
Pressure change68.0%Four-week change in activity pressure.
Leadership-22.60Latest relative-leadership reading.
RS change23.9%Four-week change in relative leadership.
04 · Fundamentals and valuation
Open full factor analysis
What investors are paying for—and the quality behind it
A published fundamentals and factor snapshot is not available for this company.
No published fundamental snapshot is available for this company.
05 · Ownership, options, and sentiment
What other market participants are doing
Options, insider transactions, market sentiment, and activity-pressure signals can confirm or challenge the price story. None should be used alone.
Insider activity-
No recent insider transactions are stored for this company.
News sentiment50/100
Weighted news tone is neutral across 1 relevant articles.
0 positive · 1 neutral · 0 negativePatient CapitalQuiet
Activity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal
06 · Catalysts and risk
What can move the shares—and how volatile the path has been
Event timing, options-implied movement, drawdown, and weekly return distribution frame the risk around the current setup.
Next earnings-No event is currently stored.
Options expected move-Nearest-chain priced movement where available.
52-week drawdown-47.4%Distance below the 52-week high.
13-week volatility7.6%Standard deviation of weekly returns.
Weekly gains and losses
Latest 26 completed weeksEach bar is one week. Gains rise above the zero line; losses fall below it. Taller bars mean a larger weekly move.
13 Feb
13 Mar
10 Apr
8 May
5 Jun
3 Jul
7 Aug
Weeks higher11 of 2615 weeks finished lower.
Best week+21.2%Week of 3 Apr.
Worst week-14.3%Week of 5 Jun.
Latest week+4.9%Week of 7 Aug.
Shape of recent returns
Strong gains5
Modest gains6
Flat weeks0
Modest losses7
Sharp losses8
Recent vol7.6%13-week weekly-return volatility.
Base vol5.8%52-week weekly-return volatility.
Up/down split17/35Count of positive and negative weeks in the 52-week window.
Average skew5.4% / -4.1%Average positive week versus average negative week.
07 · Sector and peer context
Is this stock leading—or simply moving with its group?
Sector and industry breadth distinguish company-specific strength from a broad group move.
SectorHK Healthcare
4-week rank14 / 100
Group average4.4%
Trend breadth12.0%
Trend12.0%active weekly trend signals
MD32.0%positive activity pressure
RS19.0%positive relative leadership
Four-week leaders
IndustryHK Drug Manufacturers - Specialty & Generic
4-week rank3 / 50
Group average-0.2%
Trend breadth8.0%
Trend8.0%active weekly trend signals
MD38.0%positive activity pressure
RS18.0%positive relative leadership
Four-week leaders
08 · Evidence and weekly data
The underlying research record
Every top-level statement above should be traceable to a stored market, fundamental, event, or positioning observation.
Weekly tape21/100
Trend, activity pressure, participation, and risk combine to a 21/100 tape read.
Indicator analysis10/100Latest 12-week confirmation: trend 0/12, activity pressure 0/12, relative leadership 0/12.
Activity pressure 0.07; No reversal markers Next-Week ExpectancyNegative 43.36%Next-week expectancy is negative with a 43.36% historical one-week setup read.
Adds short-term historical context without overriding trend, activity, or relative leadership. Factors50/100No published factor snapshot is available yet.
Patient CapitalQuietActivity-pressure buy-signal evidence highlights potential institutional accumulation windows.
No recent buy signal Sentiment50/100Weighted news tone is neutral across 1 relevant articles.
Luye Pharma Group Number of Employees 2026 | Employee Count & Headcount Data Insiders50/100No recent insider transaction evidence is stored.
Earnings50/100No stored earnings event is currently attached to this ticker.
| Week | Close | Return | Trend Line | Fair Value | Pressure | Leadership | Volume | Trend |
|---|---|---|---|---|---|---|---|---|
| 7 Aug 2026 | 2.13 HKD | 4.9% | 2.40 HKD | 2.85 HKD | -0.28 | -22.60 | 111.7M | Off |
| 31 Jul 2026 | 2.03 HKD | -2.4% | 2.43 HKD | 2.86 HKD | -0.51 | -27.79 | 129.7M | Off |
| 24 Jul 2026 | 2.08 HKD | 1.0% | 2.46 HKD | 2.87 HKD | -0.60 | -24.39 | 148.9M | Off |
| 17 Jul 2026 | 2.06 HKD | 7.3% | 2.48 HKD | 2.88 HKD | -0.82 | -24.86 | 473.5M | Off |
| 10 Jul 2026 | 1.92 HKD | -5.4% | 2.51 HKD | 2.89 HKD | -0.88 | -29.68 | 213.6M | Off |
| 3 Jul 2026 | 2.03 HKD | 14.0% | 2.54 HKD | 2.90 HKD | -1.01 | -23.81 | 101.4M | Off |
| 26 Jun 2026 | 1.78 HKD | -10.1% | 2.58 HKD | 2.91 HKD | -1.13 | -31.89 | 21.7M | Off |
| 19 Jun 2026 | 1.98 HKD | 4.8% | 2.62 HKD | 2.92 HKD | -0.96 | -28.98 | 268.3M | Off |
| 12 Jun 2026 | 1.89 HKD | 1.6% | 2.65 HKD | 2.93 HKD | -0.95 | -35.01 | 38.9M | Off |
| 5 Jun 2026 | 1.86 HKD | -14.3% | 2.70 HKD | 2.94 HKD | -0.66 | -37.56 | 73.5M | Off |
| 29 May 2026 | 2.17 HKD | -4.0% | 2.74 HKD | 2.95 HKD | -0.29 | -28.36 | 89.2M | Off |
| 22 May 2026 | 2.26 HKD | -3.8% | 2.77 HKD | 2.96 HKD | -0.11 | -26.88 | 100.5M | Off |
| 15 May 2026 | 2.35 HKD | -10.0% | 2.80 HKD | 2.97 HKD | 0.09 | -25.08 | 124.4M | Off |
| 8 May 2026 | 2.61 HKD | 1.6% | 2.83 HKD | 2.98 HKD | 0.38 | -18.05 | 57.6M | Off |
How to use this report
This is a completed-week research summary. It explains the available evidence and its conflicts; it does not predict a guaranteed outcome or replace your own risk assessment. Fundamental figures may refer to an earlier financial reporting period, which is shown above.